AMY BAILEY: Open Payments
NPI 1316559032 · HENDERSONVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 46 payments from 13 companies in 2025. Trend: 2023 $934 · 2024 $761 · 2025 $941
Food & beverage: $941
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $172 |
| Alkermes, Inc. | 6 | $141 |
| Collegium Pharmaceutical, Inc. | 5 | $111 |
| Teva Pharmaceuticals USA, Inc. | 5 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $94 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Vanda Pharmaceuticals Inc. | 3 | $61 |
| Supernus Pharmaceuticals, Inc. | 2 | $49 |
| Noven Therapeutics, LLC | 2 | $42 |
| Corium, LLC | 1 | $28 |
Products named: VRAYLAR, ARISTADA, Jornay PM, AUSTEDO XR, CAPLYTA, REXULTI, Qelbree, Xelstrym.
Industry payments across TN — which companies pay providers there.
